Free Medicines thanks to Retirement: Moral Hazard and Hospitalization Offsets in an NHS
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full population aged 58 to 65 in January 2004 covered by the public insurer in a Spanish region and we follow them until December 2006. We use a difference-in-differences strategy and exploit the eligibility age for Social Security to control for the endogeneity of the retirement decision. Our most conservative results show that the uniform exemption from pharmaceutical copayment granted to retired people in Spain increases the consumption of prescription medicines on average by 9.5%, total pharmaceutical expenditure by 15.2% and the costs borne by the insurer by 47.5%, without evidence of any offset effect in the form of reduced hospitalization. The impact is concentrated among individuals who were consumers of medicines for acute and other non-chronic diseases with a previous coinsurance rate in the range 30% to 40%.
|Date of creation:||29 Jul 2011|
|Contact details of provider:|| Postal: Gustav Mahlerplein 117, 1082 MS Amsterdam|
Phone: +31 (0)20 598 4580
Web page: http://www.tinbergen.nl/
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Paul V. Grootendorst, 1997. "Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator," Health Economics, John Wiley & Sons, Ltd., vol. 6(4), pages 365-382.
- Peter Scherer & Marion Devaux, 2010. "The Challenge of Financing Health Care in the Current Crisis: An Analysis Based on the OECD Data," OECD Health Working Papers 49, OECD Publishing.
- Katherine Baicker & Dana Goldman, 2011. "Patient Cost-Sharing and Healthcare Spending Growth," Journal of Economic Perspectives, American Economic Association, vol. 25(2), pages 47-68, Spring.
- Jaume Puig Junoy, 1988. "Gasto farmacéutico en España: efectos de la participación del usuario en el coste," Investigaciones Economicas, Fundación SEPI, vol. 12(1), pages 45-68, January.
- Barros, Pedro Pita & Machado, Matilde P. & Sanz-de-Galdeano, Anna, 2008.
"Moral hazard and the demand for health services: A matching estimator approach,"
Journal of Health Economics,
Elsevier, vol. 27(4), pages 1006-1025, July.
- Sanz-de-Galdeano, Anna & Machado, Matilde P. & Pita-Barros, Pedro, 2005. "Moral hazard and the demand for health services: a matching estimator approach," UC3M Working papers. Economics we055928, Universidad Carlos III de Madrid. Departamento de Economía.
- Barros, Pedro Luis Pita & Machado, Matilde Pinto & Sanz-de-Galdeano, Anna, 2006. "Moral Hazard and the Demand for Health Services: A Matching Estimator Approach," CEPR Discussion Papers 5488, C.E.P.R. Discussion Papers.
- Vincenzo Atella & Franco Peracchi & Domenico Depalo & Claudio Rossetti, 2006. "Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patients," Health Economics, John Wiley & Sons, Ltd., vol. 15(9), pages 875-892.
- Valérie Paris & Marion Devaux & Lihan Wei, 2010. "Health Systems Institutional Characteristics: A Survey of 29 OECD Countries," OECD Health Working Papers 50, OECD Publishing. Full references (including those not matched with items on IDEAS)
When requesting a correction, please mention this item's handle: RePEc:tin:wpaper:20110108. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Tinbergen Office +31 (0)10-4088900)
If references are entirely missing, you can add them using this form.